Brendan CFA's Colleagues at Xalud Therapeutics, Inc.
Brendan CFA's Contact Details
HQ
212-301-6673
212-301-6673
Location
Company
Xalud Therapeutics, Inc.
Xalud Therapeutics, Inc.
Brendan CFA's Company Details
Xalud Therapeutics is a biotechnology company developing a non-viral gene therapy platform to treat pathologic inflammation through immune modulation. The company is harnessing the power of interleukin-10 (IL-10), a potent cytokine that acts as a master regulator for multiple inflammatory pathways, to address the root cause of inflammation and subsequently restore homeostasis in the immune system. Xalud's lead product candidate, XT-150, is a locally injectable plasmid DNA gene therapy expressing IL-10 to addresses pathologic inflammation and pain.
Frequently Asked Questions about Brendan CFA
Brendan CFA currently works for Xalud Therapeutics, Inc.
Brendan CFA's role at Xalud Therapeutics, Inc is Chief Operating Officer.
Brendan CFA's email address is ***@xaludthera.com. To view Brendan CFA's full email address, please signup to ConnectPlex.
Brendan CFA works in the Biotechnology industry.
Brendan CFA's colleagues at Xalud Therapeutics, Inc. are Chuck Triano, Amy Chappell, Morgan Stokes, Kristin Murray, Doreen Stillings, Sarah Leblanc, Jeffrey Kutner and others.
Brendan CFA's phone number is null